Inside Pediatrics Winter 2016

1600 7th Avenue South Birmingham, Alabama 35233

Clinical Trials Open to Hem/Onc/BMT Patients Dr. Gregory Friedman’s innovative Phase 1 Clinical Trial of HSV G207 uses a modified virus to attack difficult-to-treat brain tumors. Dr. Friedman’s trial is the culmination of many years of hard work that began when he was a fellow at Children’s of Alabama. The trial is the true definition of developmental therapeutics, with the hope for more effective and less toxic treatments for our children battling brain cancers. We are currently recruiting patients from across the country. Contact (205) 638-5840 for more information.

16